A. Craig

发表

Bromocontryphan: post-translational bromination of tryptophan.

J. Rivier, B. Olivera, W. Gray, 1997, Biochemistry.

A Novel Post-translational Modification Involving Bromination of Tryptophan

J. Rivier, J. McIntosh, B. Olivera, 1997, The Journal of Biological Chemistry.

BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site

Heinz Ruffner, Inder M. Verma, Tony Hunter, 1999, Molecular and Cellular Biology.

Post-translationally modified neuropeptides from Conus venoms.

B. Olivera, P. Bandyopadhyay, A. Craig, 1999, European journal of biochemistry.

Structural requirements for neuropeptide Y18-36-evoked hypotension: a systematic study.

J. Rivier, A. Craig, J. Boublik, 1992, Journal of medicinal chemistry.

Determination of Phosphorylation Sites in Peptides and Proteins Employing a Volatile Edman Reagent

T. Hunter, J. Meisenhelder, W. Fischer, 1997, Journal of protein chemistry.

Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor.

S. Lahrichi, W. Vale, J. Rivier, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Evidence that gonadotropin-releasing hormone (GnRH) functions as a prolactin-releasing factor in a teleost fish (Oreochromis mossambicus) and primary structures for three native GnRH molecules.

W. Fischer, I. Parhar, E. Grau, 1997, The Journal of endocrinology.

Crystal structure of SsfS 6 , the putative C-glycosyltransferase involved in SF 2575 biosynthesis

G. Phillips, J. Thorson, R. Yennamalli, 2014 .

Enzymatic glycosylation of contulakin-G, a glycopeptide isolated from Conus venom, with a mammalian ppGalNAc-transferase.

W. Fischer, A. Craig, F. Piller, 2001, Toxicon : official journal of the International Society on Toxinology.

Sequence of two gonadotropin releasing hormones from tunicate suggest an important role of conformation in receptor activation

G. Mackie, B. Musselman, W. Fischer, 1997, FEBS letters.

Spontaneous fragmentation of cationic polystyrene chains

P. Derrick, A. Craig, 1985 .

In situ reduction suitable for matrix-assisted laser desorption/ionization and liquid secondary ionization using tris(2-carboxyethyl)phosphine.

W. Fischer, A. Craig, J. Rivier, 1993, Rapid communications in mass spectrometry : RCM.

Plasma desorption mass spectrometry coupled with conventional peptide sequencing techniques.

A. Engström, H. Bennich, A. Craig, 1987, Biomedical & environmental mass spectrometry.

Novel retinoic acid receptor ligands in Xenopus embryos.

R. Evans, B. Blumberg, D. Chakravarti, 1996, Proceedings of the National Academy of Sciences of the United States of America.

MS based scanning methodologies applied to Conus venom

W. Fischer, J. Rivier, J. McIntosh, 1995 .

Conorfamide, a Conus venom peptide belonging to the RFamide family of neuropeptides.

G. Bulaj, B. Olivera, M. Aguilar, 2002, Toxicon : official journal of the International Society on Toxinology.

Contulakin-G, an O-Glycosylated Invertebrate Neurotensin*

B. Olivera, E. Richelson, Karsten Schmidt, 1999, The Journal of Biological Chemistry.

An O-glycosylated neuroexcitatory conus peptide.

D. Yoshikami, J. Rivier, B. Olivera, 1998, Biochemistry.

alpha-Conotoxin EI, a new nicotinic acetylcholine receptor antagonist with novel selectivity.

D. Groebe, J. McIntosh, B. Olivera, 1995, Biochemistry.

Styelin D, an Extensively Modified Antimicrobial Peptide from Ascidian Hemocytes*

Steven W. Taylor, W. Fischer, R. Lehrer, 2000, The Journal of Biological Chemistry.

Total chemical synthesis and NMR characterization of the glycopeptide tx5a, a heavily post‐translationally modified conotoxin, reveals that the glycan structure is α‐d‐Gal‐(1→3)‐α‐d‐GalNAc

Guo-Ping Zhou, J. Meisenhelder, J. Stenflo, 2004 .

1H NMR studies on the solution conformation of contulakin-G and analogues

L. Kenne, A. Craig, T. Norberg, 2002 .

Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1).

J. Rivier, J. Reubi, B. Waser, 2001, Journal of medicinal chemistry.

Primary structure and function of three gonadotropin-releasing hormones, including a novel form, from an ancient teleost, herring.

W. Fischer, N. Sherwood, A. Craig, 2000, Endocrinology.

Primary structure of three forms of gonadotropin-releasing hormone (GnRH) from the pacu brain

E. Standen, W. Fischer, Minkyu Park, 1997, Regulatory Peptides.

Primary structure of solitary form of gonadotropin-releasing hormone (GnRH) in cichlid pituitary; three forms of GnRH in brain of cichlid and pumpkinseed fish

S. White, R. Fernald, W. Fischer, 1995, Regulatory Peptides.

Mammalian gonadotropin-releasing hormone (GnRH) identified by primary structure in Russian sturgeon, Acipenser gueldenstaedti

W. Fischer, N. Sherwood, A. Craig, 1995, Regulatory Peptides.

Metastable fragmentation of somatostatin-14 (SS-14) and a series of SS-14 analogs formed with liquid secondary ion mass spectrometry: Observation of fragment ions which involve unsymmetric disulfide bridge cleavage concomitant with peptide chain cleavage

J. Rivier, A. Craig, 1992 .

A strategy to assign a series of fragment ions: investigation of fragment ions involving peptide side chain and backbone cleavage

J. Rivier, H. Bennich, A. Craig, 1993 .

An expanded nomenclature scheme for labeling peptide fragmentations and its use with 'AMASS', a computer program for generating all possible fragment ion structures from known precursors.

J. Rivier, A. Craig, J. Porter, 1993, Biological mass spectrometry.

Mass spectrometric fragmentation of the peptide chain and β‐methyl lanthionine bridges of the polycyclic peptide nisin

A. Craig, 1991 .

Mass spectrometric identification of peptides present in immunized and parasitised hemolymph from honeybees without purification.

I. Fries, T. Trenczek, H. Bennich, 1989, Biochemical and biophysical research communications.

Influence of carrier molecules on the intensity of biomolecule ions in plasma desorption mass spectrometry.

H. Bennich, A. Craig, 1991, Analytical chemistry.

Structure and Biological Activity of Gonadotropin-Releasing Hormone Isoforms Isolated from Rat and Hamster Brains

W. Fischer, Minkyu Park, L. Mongiat, 2001, Neuroendocrinology.

[M + Fe − 5H]2− peptide ion composition verified by Fourier transform mass spectrometry accurate mass and tandem mass spectrometry analyses

J. Speir, A. Craig, M. Lirazan, 2000, Journal of the American Society for Mass Spectrometry.

252Cf plasma desorption mass spectrometry: recent advances and applications

A. Craig, I. Kamensky, 1987 .

Field desorption of polymers: polybutadiene

P. Derrick, A. Craig, P. Cullis, 1981 .

Production and characterization of beams of polystyrene ions

A. Craig, P. Derrick, 1986 .

Collision-induced decomposition of cationic radical polystyrene chains

P. Derrick, A. Craig, 1985 .

Gonadotropin-releasing hormone antagonists: novel members of the azaline B family.

W. Vale, J. Rivier, C. Rivier, 1995, Journal of medicinal chemistry.

Cf plasma desorption mass spectrometry of a polycyclic peptide antibiotic, nisin.

P. Roepstorff, P. F. Nielsen, A. Craig, 1988, Biomedical & environmental mass spectrometry.

Gonadotropin-releasing hormone antagonists: novel members of the azaline B family.

W. Vale, J. Rivier, C. Rivier, 1995, Journal of medicinal chemistry.

Influence of sample concentration and adsorption time on the yield of biomolecule ions in plasma desorption mass spectrometry.

H. Bennich, A. Craig, 1989, Analytical chemistry.

Two new forms of gonadotropin-releasing hormone in a protochordate and the evolutionary implications.

G. Mackie, W. Fischer, N. Sherwood, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Primary structures of two forms of gonadotropin-releasing hormone, one distinct and one conserved, from catfish brain

W. Fischer, N. Sherwood, A. Craig, 1992, Molecular and Cellular Neuroscience.

Three forms of gonadotropin-releasing hormone characterized from brains of one species.

W. Fischer, A. Elizur, Y. Zohar, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Fragmentation of tunichrome Sp-1 is dominated by an unusual gas-phase intramolecular rearrangement.

Steven W. Taylor, D. Kassel, A. Craig, 2003, Journal of Mass Spectrometry.

Fragmentation of a novel marine peptide, plicatamide, involves an unusual gas-phase intramolecular rearrangement

Steven W. Taylor, A. Craig, 2001, Journal of the American Society for Mass Spectrometry.

Plicatamide: A lead to the biosynthetic origins of the tunichromes?

A. Craig, J. A. Tincu, S. W. Taylor, 2000, Biochemical and biophysical research communications.

THE CHARACTERIZATION OF CONOTOXINS§

A. Craig, 2000 .

Gonadotropin-releasing hormone antagonists with N omega-triazolylornithine, -lysine, or -p-aminophenylalanine residues at positions 5 and 6.

J. Rivier, A. Craig, J. Dykert, 1992, Journal of medicinal chemistry.

The Disulfide Bond Arrangement in the Extracellular Domain of the Activin Type II Receptor

S. Choe, W. Fischer, W. Vale, 1999, Journal of protein chemistry.

Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutions.

W. Vale, J. Rivier, C. Rivier, 1999, Journal of medicinal chemistry.

Betidamino acid scan of the GnRH antagonist acyline.

J. Rivier, C. Rivier, C. Campen, 1997, Journal of medicinal chemistry.

Betidamino acids: versatile and constrained scaffolds for drug discovery.

J. Rivier, A. Craig, J. Porter, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Primary structure of a novel gonadotropin-releasing hormone in the brain of a teleost, Pejerrey.

W. Fischer, G. Somoza, N. Sherwood, 2001, Endocrinology.

Structural modifications of non-mammalian gonadotropin-releasing hormone (GnRH) isoforms: design of novel GnRH analogues

W. Vale, N. Sherwood, A. Craig, 1995, Regulatory Peptides.

Primary Structure and Function of Three Gonadotropin-Releasing Hormones, Including a Novel Form, from an Ancient Teleost, Herring1.

W. Fischer, Minkyu Park, N. Sherwood, 2000, Endocrinology.

Distinct sequence of gonadotropin-releasing hormone (GnRH) in dogfish brain provides insight into GnRH evolution.

W. Fischer, N. Sherwood, A. Craig, 1992, Proceedings of the National Academy of Sciences of the United States of America.

BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolites.

K. Umesono, R. Evans, B. Blumberg, 1998, Genes & development.

Matrix-assisted laser desorption analysis of corticotropin-releasing factor-binding protein and activin by means of immunoprecipitation

A. Grey Craig, Steven W. Sutton, Joan Vaughan, 1996, Photonics West.

Synthesis, purification and characterization of rat histone H2A (1-53)-NH2

Jean‐François Hernandez, J. Rivier, A. Craig, 1991 .

Characterization of the N-Linked Glycan of Recombinantly-Expressed Corticotropin Releasing Factor Binding Protein

W. Fischer, W. Vale, S. Sutton, 2000 .

Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat.

Y. Taché, W. Vale, J. Rivier, 1998, Journal of medicinal chemistry.

Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study.

C. Donaldson, W. Vale, J. Rivier, 1992, Journal of medicinal chemistry.

Expression, Purification, and Characterization of a Soluble Form of the First Extracellular Domain of the Human Type 1 Corticotropin Releasing Factor Receptor*

W. Fischer, W. Vale, J. Rivier, 2001, The Journal of Biological Chemistry.

Plasma desorption mass spectrometry of phosphopeptides: an investigation to determine the feasibility of quantifying the degree of phosphorylation.

A. Engström, H. Meyer, H. Bennich, 1991, Biological mass spectrometry.

The deuteron-nucleus effective interaction and DWBA calculations for the 90Zr(d, p)91Zr reaction

G. A. Stephens, J. Sharpey-Schafer, J. Forster, 1967 .

Chromatographic characterization of template assembled synthetic proteins (TASP) and other large peptides using narrow-bore IEC, RPHPLC, CZE and MS analysis

M. Mutter, G. Tuchscherer, Jean‐François Hernandez, 1991 .

Identification of the sites of phosphorylation in proteins using high performance liquid chromatography and mass spectrometry.

A. Craig, 2001, Methods in molecular biology.

Structure and toxicity of a peptide hepatotoxin from the cyanobacterium Oscillatoria agardhii.

J. Eriksson, J. Meriluoto, A. Sandström, 1989, Toxicon : official journal of the International Society on Toxinology.

Liquid sample plasma desorption mass spectrometry

B. Sundqvist, M. Salehpour, A. Craig, 1987 .

The T-superfamily of Conotoxins*

B. Olivera, P. Bandyopadhyay, L. Cruz, 1999, The Journal of Biological Chemistry.

Comparison of Peptide Fragmentation With Different Ionization Techniques: Variation With Sample Preparation Method of the Fragmentation of Luteinizing Hormone-Releasing Hormone Following Plasma Desorption

P. Derrick, H. Bennich, A. Craig, 1992 .

Plasma desorption mass spectrometry of non-molecular materials : positive and negative ions formed from [Cd(SC6H4-2-CH3)2]∞

D. Kinny, R. Garbutt, P. Derrick, 1992 .

Plasma desorption mass spectra of the three-dimensionally non-molecular material [Cd(SC6H4CH3-4)2]∞ formation of cadmium-containing cluster ions

R. Garbutt, P. Derrick, I. Dance, 1988 .

Total chemical synthesis and NMR characterization of the glycopeptide tx5a, a heavily post-translationally modified conotoxin, reveals that the glycan structure is alpha-D-Gal-(1-->3)-alpha-D-GalNAc.

Guo-Ping Zhou, J. Meisenhelder, J. Stenflo, 2004, European journal of biochemistry.

Characterization of Betidamino Acid-Containing Somatostatin and Gonadotropin-Releasing Hormone Analogs with Electrospray Mass Spectrometry and Tandem Mass Spectrometry

J. Rivier, A. Craig, S. Koerber, 2001 .

Design of potent dicyclic (1-5/4-10) gonadotropin releasing hormone (GnRH) antagonists.

J. Rivier, C. Rivier, A. Craig, 2000, Journal of medicinal chemistry.

Inactivation of a serotonin-gated ion channel by a polypeptide toxin from marine snails.

D. Julius, J. Rivier, B. Olivera, 1998, Science.

Constrained corticotropin-releasing factor antagonists with i-(i + 3) Glu-Lys bridges.

S. Lahrichi, W. Vale, J. Rivier, 1997, Journal of medicinal chemistry.

Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.

S. Lahrichi, W. Vale, J. Rivier, 1998, Journal of medicinal chemistry.

Defining structural requirements for neuropeptide Y receptors using truncated and conformationally restricted analogues.

J. Rivier, A. Craig, S. Koerber, 1993, Journal of medicinal chemistry.

Immunoprecipitation as a means of purification for analysis with mass spectrometry

J. Vaughan, W. Fischer, S. Sutton, 1996 .

Monitoring protein kinase and phosphatase reactions with matrix-assisted laser desorption/ionization mass spectrometry and capillary zone electrophoresis: comparison of the detection efficiency of peptide-phosphopeptide mixtures.

W. Fischer, A. Craig, J. Rivier, 1994, Biological mass spectrometry.

Single point D-substituted corticotropin-releasing factor analogues: effects on potency and physicochemical characteristics.

W. Vale, J. Rivier, C. Rivier, 1993, Journal of medicinal chemistry.

Erratum: The T-superfamily of conotoxins (Journal of Biological Chemistry (1999) (30664-30671))

B. Olivera, P. Bandyopadhyay, L. Cruz, 1999 .

SAR of corticotropin releasing factor in relation to its pituitary receptor and binding protein

W. Vale, J. Rivier, C. Rivier, 1995 .

Structure activity relationships (SAR) of corticotropin releasing factor

W. Vale, J. Rivier, C. Rivier, 1995 .

Conformationally restricted competitive antagonists of human/rat corticotropin-releasing factor.

A. Hagler, S. Lahrichi, W. Vale, 1994, Journal of medicinal chemistry.